Earnings History Data for Eton Pharmaceuticals, Inc. (ETON) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-03-2024	AH		ETON	Eton Pharmaceuticals, Inc.	112.90	-0.09	-0.04	0.04	Eton Pharmaceuticals GAAP EPS of -$0.09 misses by $0.05, revenue of $7.3M misses by $0.36M [3/14/2024 4:10 PM]	3.85	-0.61 (-13.67%)	4.20	-0.26 (-5.83%)	2.42 - 5.81	184,534	60,000	3,641
Eton Pharmaceuticals GAAP EPS of -$0.09 misses by $0.05, revenue of $7.3M misses by $0.36M [3/14/2024 4:10 PM]
09-11-2023	AH		ETON	Eton Pharmaceuticals, Inc.	114.67	-0.02	-0.10	-0.12	Eton Pharmaceuticals GAAP EPS of -$0.02, revenue of $7M [11/9/2023 4:14 PM]	3.84	-0.69 (-15.16%)	4.55	0.02 (0.44%)	2.40 - 5.81	200,224	70,000	884
Eton Pharmaceuticals GAAP EPS of -$0.02, revenue of $7M [11/9/2023 4:14 PM]
10-08-2023	AH		ETON	Eton Pharmaceuticals, Inc.	66.57	0.18	-0.09	-0.06	Eton Pharmaceuticals GAAP EPS of $0.18, revenue of $12M [8/10/2023 4:42 PM]	3.57	0.97 (37.31%)	3.41	0.81 (31.15%)	1.95 - 4.28	9,888,790	60,000	5,394,280
Eton Pharmaceuticals GAAP EPS of $0.18, revenue of $12M [8/10/2023 4:42 PM]
11-05-2023	AH	4:05 PM ET (May 11)	ETON	Eton Pharmaceuticals, Inc.	92.84	-0.10	-0.14	-0.21	Eton Pharmaceuticals GAAP EPS of -$0.10 beats by $0.04, revenue of $5.3M beats by $0.74M [5/11/2023 4:04 PM]	3.58	0.10 (3.03%)	3.56	0.09 (2.59%)	1.95 - 4.25	45,238	40,000	4,463
Eton Pharmaceuticals GAAP EPS of -$0.10 beats by $0.04, revenue of $5.3M beats by $0.74M [5/11/2023 4:04 PM]
16-03-2023	AH	4:05 PM ET (Mar 16)	ETON	Eton Pharmaceuticals, Inc.	94.36	0.04	0.01	0.04	Eton Pharmaceuticals GAAP EPS of $0.04 beats by $0.03, revenue of $8.5M misses by $0.62M [3/16/2023 4:10 PM]	3.90	-0.20 (-4.88%)	4.00	-0.10 (-2.44%)	1.95 - 4.50	163,240	60,000	284
Eton Pharmaceuticals GAAP EPS of $0.04 beats by $0.03, revenue of $8.5M misses by $0.62M [3/16/2023 4:10 PM]
10-11-2022	AH	4:00 PM ET (Nov 10)	ETON	Eton Pharmaceuticals, Inc.	65.77	-0.12	-0.15	-0.24	Eton Pharmaceuticals GAAP EPS of -$0.12, revenue of $3.22M [11/10/2022 4:24 PM]	2.97	0.46 (18.33%)	2.79	0.28 (11.16%)	1.95 - 5.23	237,649	90,000	138
Eton Pharmaceuticals GAAP EPS of -$0.12, revenue of $3.22M [11/10/2022 4:24 PM] Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results [Nov-10-22 04:05PM]
11-08-2022	AH	4:00 PM ET (Aug 11)	ETON	Eton Pharmaceuticals, Inc.	68.61	-0.06	0.03	-0.08	Eton Pharmaceuticals GAAP EPS of -$0.06 misses by $0.09, revenue of $7.4M misses by $0.36M [8/11/2022 4:03 PM]	2.97	-0.04 (-1.33%)	2.75	-0.26 (-8.64%)	2.47 - 6.72	206,730	60,000	100
Eton Pharmaceuticals GAAP EPS of -$0.06 misses by $0.09, revenue of $7.4M misses by $0.36M [8/11/2022 4:03 PM] Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results [Aug-11-22 04:01PM] Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Misses Revenue Estimates [Aug-11-22 05:35PM]
12-05-2022	AH	4:00 PM ET (May 12)	ETON	Eton Pharmaceuticals, Inc.	77.57	-0.21	-0.08	0.19	Eton Pharmaceuticals GAAP EPS of -$0.21, revenue of $2.18M [5/12/2022 4:21 PM]	3.24	0.35 (12.11%)	2.92	0.03 (1.04%)	2.76 - 8.90	153,715	60,000	2,106
Eton Pharmaceuticals GAAP EPS of -$0.21, revenue of $2.18M [5/12/2022 4:21 PM] Eton Pharmaceuticals Reports First Quarter 2022 Financial Results [May-12-22 04:02PM] Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Lags Revenue Estimates [May-12-22 05:15PM] Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Profit Outlook [May-13-22 09:08AM]
16-03-2022	AH	4:05 PM ET (Mar 16)	ETON	Eton Pharmaceuticals, Inc.	94.73	0.04	0.05	-0.32	Eton Pharmaceuticals GAAP EPS of $0.04 misses by $0.01, revenue of $6.09M misses by $1.47M [3/16/2022 4:06 PM]	4.18	0.25 (6.36%)	4.07	0.14 (3.56%)	3.01 - 8.90	266,919	151,180	6,944
Eton Pharmaceuticals GAAP EPS of $0.04 misses by $0.01, revenue of $6.09M misses by $1.47M [3/16/2022 4:06 PM] Eton Pharmaceuticals Reports Fourth Quarter 2021 Financial Results [Mar-16-22 04:02PM]
15-11-2021	AH	4:00 PM ET (Nov 15)	ETON	Eton Pharmaceuticals, Inc.	119.80	-0.24	-0.14	-0.31	Eton Pharmaceuticals EPS misses by $0.10, misses on revenue [11/15/2021 4:17 PM]	4.84	-0.27 (-5.28%)	4.55	-0.56 (-10.96%)	4.03 - 10.30	581,054	900,000	13,820
Eton Pharmaceuticals in pact with Tolmar to jointly promote ALKINDI SPRINKLE [11/15/2021 7:32 AM] Eton Pharmaceuticals EPS misses by $0.10, misses on revenue [11/15/2021 4:17 PM] Warning: ETON is at high risk of performing badly [11/16/2021 4:54 AM] Eton Pharmaceuticals Announces Co-Promotion Agreement with Tolmar Pharmaceuticals for ALKINDI SPRINKLE® [Nov-15-21 06:30AM] Eton Pharmaceuticals Reports Third Quarter Financial Results [Nov-15-21 04:05PM] Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Misses Revenue Estimates [Nov-15-21 06:45PM]
16-08-2021	AH	4:05 PM ET (Aug 16)	ETON	Eton Pharmaceuticals, Inc.	143.86	-0.08	-0.14	-0.23	Eton Pharmaceuticals EPS beats by $0.06, misses on revenue [8/16/2021 4:11 PM]	4.19	-0.05 (-1.18%)	4.24	0.0 (0.00%)	4.03 - 10.30	499,238	1,210,000	9,796
Eton Pharma urged to address misleading claims linked to Alkindi Sprinkle [8/16/2021 12:33 PM] Eton Pharmaceuticals EPS beats by $0.06, misses on revenue [8/16/2021 4:11 PM] Eton Pharmaceuticals Reports Second Quarter Financial Results [Aug-16-21 04:02PM] Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Misses Revenue Estimates [Aug-16-21 05:25PM]
13-05-2021	AH	4:00 PM ET (May 13)	ETON	Eton Pharmaceuticals, Inc.	193.66	0.19	0.19	-0.50	Eton Pharmaceuticals EPS in-line, misses on revenue [5/13/2021 4:25 PM]	8.23	0.50 (6.47%)	8.00	0.27 (3.49%)	4.33 - 10.30	426,341	250,000	1,809
Eton Pharmaceuticals EPS in-line, misses on revenue [5/13/2021 4:25 PM] Eton Pharmaceuticals, Inc. to Host Earnings Call [May-13-21 02:30PM] Eton Pharmaceuticals Reports Record Revenue and Earnings [May-13-21 04:05PM] Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Meet Estimates [May-13-21 06:45PM]
16-03-2021	AH	4:05 PM ET (Mar 16)	ETON	Eton Pharmaceuticals, Inc.	198.79	-0.32	-0.27	-0.15	Eton Pharmaceuticals EPS misses by $0.06, misses on revenue [3/16/2021 4:21 PM]	8.02	0.10 (1.26%)	7.80	0.02 (0.26%)	2.50 - 10.30	202,301	201,046	0
Eton Pharmaceuticals EPS misses by $0.06, misses on revenue [3/16/2021 4:21 PM] Eton Pharmaceuticals, Inc. to Host Earnings Call [Mar-16-21 02:30PM] Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results [Mar-16-21 04:02PM] Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates [Mar-16-21 05:15PM] Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors [Mar-17-21 04:05PM]
12-11-2020	AH		ETON	Eton Pharmaceuticals, Inc.	165.82	-0.31	-0.26	-0.28	Eton Pharmaceuticals EPS misses by $0.06 [11/12/2020 4:24 PM]	7.18	-0.06 (-2.84%)	7.35	-0.04 (-0.54%)	2.50 - 9.12	265,389	249,641	14,251

12-08-2020	PM		ETON	Eton Pharmaceuticals, Inc.	164.09	-0.23	-0.28	-0.18	Eton Pharmaceuticals EPS beats by $0.03, misses on revenue [8/12/2020 8:32 AM]	6.72	0.34 (5.41%)	6.18	-0.20 (-3.06%)	2.50 - 8.74	222,574	841,367	8,695

14-05-2020	AH		ETON	Eton Pharmaceuticals, Inc.	113.29	-0.50	-0.24	-0.42	Eton Pharmaceuticals EPS misses by $0.28, misses on revenue [5/14/2020 4:17 PM]	4.75	-0.45 (-8.65%)	4.85	0.25 (5.43%)	2.50 - 9.07	158,056	65,387	0